Today (Wednesday 4 August) researchers in the U.S. have published findings describing how levels of the hallmark Alzheimer's protein, amyloid in midlife are linked to subsequent decline in memory and thinking in later life. ...
Aug 5, 2021
0
11
Dementia is a thief. It steals a person's memory, their ability to reason, to live independently.
Jul 30, 2021
0
52
Australians living with mild cognitive impairment (MCI) could know five years in advance whether they are at high risk of developing Alzheimer's disease—the most common form of dementia—according to new research from ...
Jul 28, 2021
0
5
An EPFL scientist has found that brain fingerprints—or maps of the neural connections within our brain—can be used to detect a decline in cognitive ability. That's because the fingerprints are harder to detect in people ...
Jul 27, 2021
0
949
A new study by researchers from the Neurosciences Research Centre at St George's has identified the strengths and limitations of different tasks used to detect the early signs of Alzheimer's disease through speech analysis ...
Jul 13, 2021
1
25
New research suggests one year of moderate-to-vigorous intensity aerobic exercise training improved cardiorespiratory fitness, cerebral blood flow regulation, memory and executive function in people with mild cognitive impairment. ...
Jul 6, 2021
0
14
Researchers have developed an artificial intelligence (AI)-based brain age prediction model to quantify deviations from a healthy brain-aging trajectory in patients with mild cognitive impairment, according to a study published ...
Jun 23, 2021
0
5
The use of statin therapy in adults 65 years old or older is not associated with incident dementia, mild cognitive impairment (MCI) or decline in individual cognition domains, according to a study published in the Journal ...
Jun 21, 2021
0
12
In patients with mild cognitive impairment, taking lipophilic statins more than doubles their risk of developing dementia compared to those who do not take statins. According to research presented at the Society of Nuclear ...
Jun 15, 2021
0
28
Earlier this week, the federal Food and Drug Administration (FDA) approved the use of the drug aducanumab to treat Alzheimer's disease—making it the first new drug in nearly 20-years to treat the disease. Aducanumab is ...
Jun 10, 2021
0
0
